Key Market Indicators
The blood and blood forming organs medicine market in Australia is expected to reach $766.2 million by 2026. This is a 2.3% year-on-year increase from 2021, when it was valued at $660.8 million. Since 1995, the market has been growing at a rate of 5.9% year-on-year. In 2021, Australia ranked 10th in the world in terms of market size, with Belgium overtaking it at $660.8 million. Germany, Italy and South Korea came in at numbers 2, 3 and 4 respectively. The prevalence of anemia in Australia is expected to reach 30,200 hospital discharges by 2026, a 1% year-on-year increase from 2021 when it was 28,390 discharges. Since 1998, demand has been up by 1.2% year-on-year. In 2021, Australia came in 6th in the world, with Italy ahead at 28,390 discharges. Germany, the United Kingdom and Poland respectively ranked numbers 2, 3 and 4 in this ranking.
